Society of Cardiovascular Computed Tomography’s Post

In the year since Wellstar MCG Health Medical Center joined Wellstar, our team has advanced patient care to provide innovative treatment to the Central Savannah River Area. As an academic medical center, Wellstar MCG Health is able to offer new, groundbreaking diagnostic and treatment options. It was the first hospital in the area to offer the Galleri Test multi-cancer early detection blood test, which uses a single blood draw to detect more than 50 types of cancer. Our electrophysiology lab also became the first in Georgia to implant an extravascular implantable cardioverter-defibrillator (EV-ICD). This device treats people at risk for dangerous heart rhythms and life-threatening cardiac arrest. Learn more about how Wellstar is caring for the Augusta area at http://spr.ly/6042vSVj4.

Delray Medical is the first hospital in South Florida to enroll a patient in the PICASSO trial, aimed at improving management for stroke patients with tandem occlusions. Tandem occlusions occur when a stroke in the brain is accompanied by a narrowing or blockage in the neck artery, limiting blood flow to critical areas. The PICASSO trial compares two distinct treatment approaches: stenting the artery to keep it open or performing angioplasty, a minimally invasive procedure that uses a balloon to restore blood flow. The PICASSO National Steering Committee praised the team at Delray Medical Center for their dedication to advancing stroke care.  Read more: https://bit.ly/4g0lJlF

Director of Electrophysiology Dr. Riple Hansalia and Dr. Tatjana Sljapic performed the first patient cases in New Jersey with Medtronic's Afferra Mapping and Ablation System at Jersey Shore University Medical Center. This state-of-the-art, next generation system optimizes ablation procedures, treating persistent atrial fibrillation. I'm thrilled Jersey Shore's cardiovascular experts are continuing to transform care for patients, now in the new $45 million CV Suite at the academic medical center! Hackensack Meridian Health Vito Buccellato, MPA, LNHA Brian Walch Brett Sealove https://bit.ly/4g75jYl

If you watch football on TV, you might have seen it before: out of nowhere a seemingly healthy athlete collapses onto the field. This is how Sudden Cardiac Death (SCD) strikes. Coronary artery anomalies (CAA), like anomalous aortic origin of coronary artery (AAOCA) and myocardial bridges (MB) are associated with Sudden Cardiac Death, with AAOCA being a leading cause of SCD in young athletes. But while the association is clear, the diagnosis and management of these conditions are not. Can patients even risk exercise after a diagnosis? Are the methods of diagnosis clear enough to merit ending an athlete’s career for good? If you’re interested the answers to these questions and learning more about CAA, join me and my colleagues as we host the 6th annual Coronary Artery Anomalies Symposium, December 5th – 7th. There we will discuss the challenges of diagnosing and managing these conditions, how to use advanced imaging modalities to accurately diagnose them, dig into the risk factors and more. Learn more about this event and RSVP here: https://lnkd.in/gHNT-5rf

In a new interview, Tom C. Nguyen, MD, chief medical executive of Baptist Health Miami Cardiac & Vascular Institute, describes the evolving roles of TAVR and SAVR in aortic valve disease, noting the importance of long-term data and multidisciplinary collaboration. Watch here: https://lnkd.in/ecUua_we #Cardiology #MedicalNews

To ensure that New Mexicans can receive local treatment for conditions like stroke, aneurysms, blocked carotid arteries and other neurological and cardiovascular surgical issues, Presbyterian has embarked on an exciting project. A new hybrid operating room at Presbyterian Hospital is designed to improve access to advanced neuroscience and heart/vascular care, and will elevate our ability to care for more patients with more complex needs. #PhilanthropicImpact Learn more about the hybrid OR and much more in the most recent issue of our Giving Newsletter: https://lnkd.in/gnBuNw7n

JACC: Advances-November 2024 State-of-the-Art Review Future Training Pathways in Percutaneous Coronary Interventions: Interventional Critical Care, Complex Coronary Interventions, and Interventional Heart Failure

Our latest case will highlight the utility in using Cardiac PET/CT in assessing STENT patentcy post revascularization with patients experiencing a new onset of chestpain. View case: https://lnkd.in/eyUMauDU #CardiacPET #N13Ammonia

We're proud to announce the official opening of our state-of-the-art Cath Lab—a game-changing facility dedicated to advancing cardiovascular research. This Cath lab is designed to explore new diagnostic and therapeutic techniques with minimized radiation exposure and high-quality imaging. Dr. Emerson C. Perin highlighted the lab’s unique role in advancing pre-clinical research. “This is not only the best Cath Lab in the world because of its state-of-the-art equipment but also because it provides the platform to pioneer techniques that will ultimately save lives.” Read the full story: https://lnkd.in/gXfXTPhb #MedicalInnovation #CardiologyResearch #HeartCare

#ESC_HFA tutorial | Guideline recommended medical therapy - Implications of current publications and guidelines for daily clinical practice! https://ow.ly/KpJ150RyCkQ Join Peter Rainer and Mauro Feola in tutorial room 3 on 13 May at 12:30 to learn: 🌟When GRMT becomes effective showing an impact on patient outcomes (PR) 🌟What impact specifically SGLT2i have on cardiovascular mortality and sudden cardiac death (MF) Sponsored by ZOLL Cardiac Management Solutions #Cardiology